SGEN - Seattle Genetics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-222,693-125,530-140,111-120,486
Operating Activities, Cash Flows Provided By or Used In
Depreciation26,03224,26918,03414,505
Adjustments To Net Income47,023-2,98956,33543,761
Changes In Accounts Receivables-45,233-22,846-8,998-13,682
Changes In Liabilities-8372,220-6,692-41,837
Changes In Inventories6,7398,146-11,161-13,512
Changes In Other Operating Activities-14,567-2,170-4,378-1,952
Total Cash Flow From Operating Activities-203,536-118,900-96,971-133,203
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-21,219-28,722-27,835-13,392
Investments26,740200,24096,028-362,458
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-592,630129,86168,193-375,850
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings----
Other Cash Flows from Financing Activities----
Total Cash Flows From Financing Activities713,40741,31135,196554,381
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents-82,75952,2726,41845,328